"
Team:Waterloo
From 2014.igem.org
(Difference between revisions)
m |
|||
| (2 intermediate revisions not shown) | |||
| Line 12: | Line 12: | ||
<div class="blueOnGrey"> | <div class="blueOnGrey"> | ||
<h1>Staphylocide</h1> | <h1>Staphylocide</h1> | ||
| - | <h3 style="text-align: center"> | + | <h3 style="text-align: center">Delivery of an Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation</h3> |
</div> | </div> | ||
<!--Content below images--> | <!--Content below images--> | ||
Latest revision as of 02:33, 18 October 2014
Staphylocide
Delivery of an Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation
Problem
MRSA is sweeping the nation, an antibiotic-resistant scourge migrating from hospitals into communities. We need a hero to fight it and Waterloo iGEM has designed a synthetic bacterium that just might do the trick...
Solution
...Staphylocide! Staphylocide delivers antibiotic resistance gene silencing in vivo and could one day be incorporated into a treatment that would help doctors defeat MRSA once and for all.
Project Cornerstones
Explore the three cornerstones of this year's project: delivering the silencing in vivo using conjugation, silencing mecA expression using CRISPRi and sRNA and translating from the lab to the patients.
